Status:

UNKNOWN

The HIFUB Study (HIFU in Breast Cancer)

Lead Sponsor:

University of Oxford

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

High Intensity Focused Ultrasound (HIFU) is a new method of treating solid tumours by thermally ablating them. It has been used in a number of different types of cancers but there is little informatio...

Eligibility Criteria

Inclusion

  • Participant is willing and able to give informed consent for participation in the trial.
  • Female, aged 18 years or above.
  • Histologically confirmed breast cancer (invasive ductal cancer) by core biopsy, which is suitable for surgical resection.
  • Participants must have one non-metastatic, clinically palpable, invasive breast cancer measuring ≤2cm in its largest dimension, which can be visualised using diagnostic ultrasound.
  • All participants must have an adequate biopsy determination of oestrogen, progesterone, HER2 receptor status on pre-operative biopsy.
  • Adequate ECG, haematological, renal and hepatic function, as indicated, as would be required for imaging and surgery.
  • In the Investigator's opinion, is able and willing to comply with all trial requirements.

Exclusion

  • Female participant who is pregnant.
  • Significant renal or hepatic impairment.
  • An inadequate biopsy determination of oestrogen, progesterone, HER2 receptor status on pre-operative biopsy.
  • Unable to visualize lesion or tumour boundaries clearly on ultrasound.
  • Subjects with tumours lying less than 5mm to overlying skin or less than 5mm to the underlying muscle on the diagnostic scan.
  • Any uncontrolled illness or any other medical problem that would preclude surgery.
  • The presence of any contraindication for magnetic resonance imaging, e.g. the presence of a heart pacemaker, a metallic foreign body (metal sliver) in the eye, or an aneurysm clip in the brain or severe claustrophobia.

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2022

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT05350059

Start Date

May 1 2022

End Date

November 1 2022

Last Update

April 27 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.